,The U.S. Food and Drug Administration issued draft guidance outlining its approach to evaluating premarket applications for flavored e-cigarettes, with a focus on balancing risks to youth and potential benefits to adult smokers. The guidance specifies that manufacturers must demonstrate a significant added benefit of flavored e-cigarettes compared to tobacco-flavored products, particularly in supporting smoking cessation or reduction among adults. It also emphasizes the need for robust scientific evidence to justify that such benefits outweigh the risks of youth initiation and use. The draft introduces a risk-proportionate assessment framework, including evidence requirements for evaluating youth exposure, study approaches to assess behavioral impact, and consideration of novel access restriction technologies aimed at preventing underage use. Public consultation on the draft guidance is open until May 11, 2026, after which the agency will consider feedback before finalizing the document. The guidance, once finalized, will represent the agency's current thinking on regulatory expectations for flavored e-cigarette applications. The measures aim to strengthen regulatory oversight of flavored nicotine products and reduce youth uptake while supporting harm reduction for adult smokers.
Consult
